ATF3 and Myocardial fibrosis: Consistently, infarct size and myocardial fibrosis levels were reduced in mice with ATF3 downregulation, while SPHK1 overexpression decreased the anti‐fibrotic effect of ATF3 downregulation in MI mice (Figure 6E).